Table 2.
Comparison of clinical characteristics between patients with primary viral pneumonia caused by pandemic 2009 influenza A (H1N1) virus infection who received macrolides and those who received no macrolides
| Variables | No macrolide-based treatment N = 543 |
Macrolide-based treatment N = 190 |
p |
|---|---|---|---|
|
Invasive mechanical ventilation n (%) |
357 (66.7) | 118 (62.1) | 0.2 |
|
Septic shock n (%) |
268 (50.5) | 82 (43.4) | 0.09 |
|
MODS n (%) |
341 (63.4) | 104 (55.0) | 0.04 |
|
CRRT n (%) |
58 (10.8) | 14 (7.4) | 0.2 |
|
Empirical oseltamivir n (%) |
555 (99.6) | 175 (97.7) | 0.01 |
|
Corticosteroids n (%) |
216 (39.2) | 91 (53.2) | 0.001 |
MODS multiple organ dysfunction syndrome, CRRT continuous renal replacement therapy